?

Can [blood-based biomarkers](/diagnostics/plasma-biomarkers) (NfL, GFAP, p-tau effectively stratify FTD subtypes?

active
open question Created: 2026-04-25T20:29:13 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-346b30e3-23e7-4a04-8d56-41
Open Question open Wiki: diseases-ftd
Can [blood-based biomarkers](/diagnostics/plasma-biomarkers) (NfL, GFAP, p-tau effectively stratify FTD subtypes?
Importance Elo
1500
Field Rank
Rank #229 in diseases
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page diseases-ftd
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
diseases
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:13.685340'}
field_tagdiseases
source_iddiseases-ftd
sub_fieldftd
source_kindwiki
question_hash278db13435e8230bbc40f1afbed60e3ff407c0e7fa30239c5d4c34723c664a8d
question_textCan [blood-based biomarkers](/diagnostics/plasma-biomarkers) (NfL, GFAP, p-tau effectively stratify FTD subtypes?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page diseases-ftd
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.